Q3 FY2026 · ended Sep 30, 2026 · Revenue $72.05M, -19.4% YoY · Filed Oct 26, 2026
Medifast, Inc. (MED) files with the SEC under industry code 2090, Miscellaneous Food Preparations & Kindred Products. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $72.0 million and a net loss of $17.5 million. Free cash flow was $2.9 million. As of Sep 30, 2026 it held $172.5 million in cash and investments and $20.7 million in total debt.
Company profile
- Industry
- Miscellaneous Food Preparations & Kindred Products (SIC 2090)
- Listed as
- MED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 910329
- Former names
- HEALTHRITE INC (until Jan 9, 2001)
Other Miscellaneous Food Preparations & Kindred Products companies
- Mccormick & Co Inc MKC
- Utz Brands, Inc. UTZ
- Coffee Holding Co Inc JVA
- Top Wealth Group Holding Ltd TWG
All 5 Miscellaneous Food Preparations & Kindred Products companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $72.0M | $76.4M | $76.0M | $75.1M | $89.4M |
| Operating income | -$19.4M | -$4.3M | -$3.3M | -$7.8M | -$4.1M |
| Net income | -$17.5M | -$3.1M | -$2.1M | -$18.1M | -$2.3M |
| Diluted EPS | -$1.57 | -$0.28 | -$0.19 | -$1.65 | -$0.21 |
| Operating cash flow | $3.3M | $1.7M | $260,000 | -$5.3M | $12.1M |
| Free cash flow | $2.9M | $728,000 | -$836,000 | -$6.6M | $10.8M |
| Total assets | $239.8M | $260.4M | $252.0M | $248.0M | $268.2M |
| Total liabilities | $59.5M | $64.0M | $54.4M | $49.1M | $53.5M |
| Stockholders' equity | $180.3M | $196.4M | $197.7M | $198.9M | $214.7M |
| Cash and investments | $172.5M | $169.8M | $168.9M | $167.3M | $173.5M |
| Total debt | $20.7M | $27.6M | $16.1M | $10.7M | $12.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 26, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2026 | Oct 26, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2026 | May 29, 2026 |
All 1000 Medifast, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.